Texas Capital Bancshares (TCBI) fundamentals: P/E, valuation, undervalued?

Texas Capital Bancshares · Financials · ref. ETF XLF · price $89.65
Logo Texas Capital BancsharesSee the full Texas Capital Bancshares (TCBI) profile
In short — Texas Capital Bancshares trades at 11.7× earnings (P/E), 10.9× forward, with a net margin of 28.7 % and revenue growth of +9 %. Read: Cheap for the growth (P/E 11 for ~16% growth (PEG 0.7)).

Is Texas Capital Bancshares stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.

📈 1-year price
$89.65+5.1% over range
Oct 14, 25low $77.08 · high $107.74Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
25% recommend buying · 8 analysts
Valuation : Cheap for the growth — P/E 11 for ~16% growth (PEG 0.7)

Valuation

11.7
P/E (price/earnings)
10.9
Forward P/E
0.74
PEG
1.2
Price/book (P/B)
$3.9B
Market cap
7.69
EPS

Profitability & growth

28.7 %
Net margin
+9 %
Revenue growth
+16 %
Earnings growth
$893M
Total debt

Texas Capital Bancshares income statement

Fiscal yearRevenueNet incomeMargin
2022$977M$315M32.3 %
2023$1.1B$172M16.0 %
2024$1.1B$60M5.4 %
2025$1.3B$313M24.9 %
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.

Frequently asked questions

What is Texas Capital Bancshares's P/E and is the stock undervalued? What's a good P/E?

Texas Capital Bancshares's P/E is 11.7 (forward 10.9). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".

Is Texas Capital Bancshares profitable?

Texas Capital Bancshares has a net margin of 28.7 % (EPS 7.69). The company is profitable.

Is TCBI stock expensive?

Our read: "Cheap for the growth" — P/E 11 for ~16% growth (PEG 0.7). Cross-check with growth and sector.

💬 A question about Texas Capital Bancshares? The JPI assistant answers using our backtest data.
Keep exploring Texas Capital Bancshares
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)